Literature DB >> 8040336

LAP (NF-IL6) transactivates the collagen alpha 1(I) gene from a 5' regulatory region.

K Houglum1, M Buck, V Adir, M Chojkier.   

Abstract

Although collagen is known to enhance hepatocyte differentiation and hepatocytes produce collagen in vivo, the transcriptional factors responsible for collagen type I gene expression in hepatic cells are not known. LAP (Liver Activator Protein) is a member of the C/EBP family, which in differentiated hepatocytes contributes to the high levels of liver-specific gene expression. In this study we show that LAP binds to the collagen alpha 1(I) promoter at both reverse CCAAT motifs and activates transcription. Furthermore, an upstream element, collagen element I (-370/-344), which shares homology with the LAP binding cis-element of the albumin promoter (9 of 13 bp) is described. This collagen element I stimulates transcription in both orientations and when placed in front of either a homologous or a heterologous chimeric report construct. These experiments suggest that LAP may be important in the expression of collagen in differentiated hepatocytes through both the promoter and a newly described upstream element.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8040336      PMCID: PMC296161          DOI: 10.1172/JCI117400

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  Identification of protein binding sites in genomic DNA by two-dimensional gel electrophoresis.

Authors:  A Boffini; P Prentki
Journal:  Nucleic Acids Res       Date:  1991-04-11       Impact factor: 16.971

2.  DNA sequences in the first intron of the human pro-alpha 1(I) collagen gene enhance transcription.

Authors:  C M Rossouw; W P Vergeer; S J du Plooy; M P Bernard; F Ramirez; W J de Wet
Journal:  J Biol Chem       Date:  1987-11-05       Impact factor: 5.157

Review 3.  Role of phosphoinositides in the regulation of liver function.

Authors:  J H Exton
Journal:  Hepatology       Date:  1988 Jan-Feb       Impact factor: 17.425

Review 4.  Therapeutic strategies for hepatic fibrosis.

Authors:  M Chojkier; D A Brenner
Journal:  Hepatology       Date:  1988 Jan-Feb       Impact factor: 17.425

5.  Extracellular matrix components influence DNA synthesis of rat hepatocytes in primary culture.

Authors:  N Sawada; A Tomomura; C A Sattler; G L Sattler; H K Kleinman; H C Pitot
Journal:  Exp Cell Res       Date:  1986-12       Impact factor: 3.905

6.  d-alpha-tocopherol inhibits collagen alpha 1(I) gene expression in cultured human fibroblasts. Modulation of constitutive collagen gene expression by lipid peroxidation.

Authors:  K Houglum; D A Brenner; M Chojkier
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

7.  Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts.

Authors:  R Raghow; A E Postlethwaite; J Keski-Oja; H L Moses; A H Kang
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

8.  Hepatocyte collagen production in vivo in normal rats.

Authors:  M Chojkier
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

9.  Cell types involved in collagen and fibronectin production in normal and fibrotic human liver.

Authors:  B Clement; J A Grimaud; J P Campion; Y Deugnier; A Guillouzo
Journal:  Hepatology       Date:  1986 Mar-Apr       Impact factor: 17.425

10.  Acetaldehyde increases collagen gene transcription in cultured human fibroblasts.

Authors:  D A Brenner; M Chojkier
Journal:  J Biol Chem       Date:  1987-12-25       Impact factor: 5.157

View more
  10 in total

1.  Two different cis-acting regulatory regions direct cell-specific transcription of the collagen alpha 1(I) gene in hepatic stellate cells and in skin and tendon fibroblasts.

Authors:  K Houglum; M Buck; J Alcorn; S Contreras; P Bornstein; M Chojkier
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

2.  Mesenchymal-specific deletion of C/EBPβ suppresses pulmonary fibrosis.

Authors:  Biao Hu; Zhe Wu; Taku Nakashima; Sem H Phan
Journal:  Am J Pathol       Date:  2012-04-11       Impact factor: 4.307

3.  Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression.

Authors:  K S Lee; M Buck; K Houglum; M Chojkier
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

4.  C/EBP-beta modulates transcription of tubulointerstitial nephritis antigen in obstructive uropathy.

Authors:  Ping Xie; Lin Sun; Baibasawata Nayak; Yoshisuke Haruna; Fu-you Liu; Naoki Kashihara; Yashpal S Kanwar
Journal:  J Am Soc Nephrol       Date:  2009-03-18       Impact factor: 10.121

Review 5.  Similarities and differences in the pathogenesis of alcoholic and nonalcoholic steatohepatitis.

Authors:  Wing-Kin Syn; Vanessa Teaberry; Steve S Choi; Anna Mae Diehl
Journal:  Semin Liver Dis       Date:  2009-04-22       Impact factor: 6.115

6.  Molecular inversion probe analysis detects novel copy number alterations in Ewing sarcoma.

Authors:  Mona S Jahromi; Angelica R Putnam; Colleen Druzgal; Jennifer Wright; Holly Spraker-Perlman; Michelle Kinsey; Holly Zhou; Kenneth M Boucher; R Lor Randall; Kevin B Jones; David Lucas; Andrew Rosenberg; Dafydd Thomas; Stephen L Lessnick; Joshua D Schiffman
Journal:  Cancer Genet       Date:  2012 Jul-Aug

Review 7.  Metabolic syndrome in the elderly.

Authors:  Matthew Bechtold; John Palmer; Joshua Valtos; Catherine Iasiello; James Sowers
Journal:  Curr Diab Rep       Date:  2006-02       Impact factor: 4.810

8.  Toll-like receptor 2 activation and serum amyloid A regulate smooth muscle cell extracellular matrix.

Authors:  Stephanie E Seidl; Lawrence G Pessolano; Christopher A Bishop; Michael Best; Celeste B Rich; Phillip J Stone; Barbara M Schreiber
Journal:  PLoS One       Date:  2017-03-03       Impact factor: 3.240

9.  The serum amyloid A3 promoter-driven luciferase reporter mice is a valuable tool to image early renal fibrosis development and shows the therapeutic effect of glucosyl-hesperidin treatment.

Authors:  Thanutchaporn Kumrungsee; Taishi Kariya; Kotaro Hashimoto; Takayuki Koyano; Nao Yazawa; Takao Hashimoto; Yohei Sanada; Makoto Matsuyama; Yusuke Sotomaru; Hiroaki Sakurai; Fons A J van de Loo; Noriyuki Yanaka
Journal:  Sci Rep       Date:  2019-10-01       Impact factor: 4.379

10.  Antifibrotic effects of roscovitine in normal and scleroderma fibroblasts.

Authors:  Richard A Steinman; Andria Rasile Robinson; Carol A Feghali-Bostwick
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.